Skip to main content
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.730
-0.260 (-5.21%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Atara Biotherapeutics Revenue

In the year 2025, Atara Biotherapeutics had annual revenue of $120.77M, down -6.33%. Atara Biotherapeutics had revenue of $1.60M in the quarter ending December 31, 2025, a decrease of -95.13%.

Revenue (ttm)
$120.77M
Revenue Growth
-6.33%
P/S Ratio
0.32
Revenue / Employee
$8,626,571
Employees
14
Market Cap
38.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025120.77M-8.17M-6.33%
Dec 31, 2024128.94M120.37M1,404.02%
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cue Biopharma 27.47M
Veru Inc. 16.89M
Palatin Technologies 8.96M
Plus Therapeutics 5.21M
Aligos Therapeutics 2.19M
RenovoRx 1.12M
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

ATRA News

More News